T-cell immunity in acute coronary syndromes

Mayo Clinic Proceedings

Volumn 76, Issue 10, 2001, Pages 1011-1020

  Weyand, Cornelia M ^a   Goronzy, Jörg J ^a   Liuzzo, Giovanna ^a,b   Kopecky, Stephen L ^a   Holmes, David R ^a   Frye, Robert L ^a  

^a MAYO CLINIC   (United States)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

ACS = acute coronary syndrome; CAD = coronary artery disease; CD = cluster of differentiation; IFN = interferon; IL = interleukin; NK = natural killer; STAT = signal transducers and activators of transcription

Indexed keywords

CYTOKINE;

ATHEROMA; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL INJURY; CELLULAR IMMUNITY; CORONARY ARTERY DISEASE; CYTOKINE RELEASE; DELAYED HYPERSENSITIVITY; INFLAMMATION; LYMPHOCYTIC INFILTRATION; MACROPHAGE; NATURAL KILLER CELL; REVIEW; T LYMPHOCYTE;

EID: 0034778761     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/76.10.1011     Document Type: Review

References (73)

1. Atherosclerosis is an inflammatory disease
2. C-reactive protein, inflammation, and coronary risk
3. C-reactive protein as a cardiovascular risk factor: More than an epiphenomenon?
4. Inflammation, the endothelium, and the acute coronary syndromes
5. Function of C-reactive protein
6. + T cell demographics and dynamics in lymphatic tissues
7. Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes
8. Innate pathways that control acquired immunity
9. The instructive role of innate immunity in the acquired immune response
10. CD1 expression in human atherosclerosis: A potential mechanism for T cell activation by foam cells
11. The role of adaptive immunity in atherosclerosis
12. Coronary plaque disruption
13. Plaque disruption and thrombosis: Potential role of inflammation and infection
14. Coronary atherosclerosis: Determinants of plaque rupture
15. Inflammation and acute coronary syndromes
16. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization
17. Monocytes/macrophages in atherosclerosis
18. Coronary atherosclerotic plaques with and without thrombus in ischemic heart syndromes: A morphologic, immunohistochemical, and biochemical study
19. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology
20. Association of coronary plaque rupture and atherosclerotic inflammation
21. The symptomatic carotid plaque
22. Immunohistochemical characterization of immune cell composition and cytokine receptor expression in human coronary atherectomy tissue
23. Recent activation of the plaque immune response in coronary lesions underlying acute coronary syndromes
24. Chronic infection and coronary artery disease
25. Infectious aspects of atherosclerosis
26. Chlamydia pneumonia (and other infective agents) in atherosclerosis and acute coronary syndromes: How good is the evidence?
27. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study
28. Inflammation, infection, or both in atherosclerosis: The ROXIS trial in perspective
29. The ACADEMIC study in perspective (Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia)
30. Rationale and design of a secondary prevention trial of antibiotic use in patients after myocardial infarction: The WIZARD (Weekly Intervention with Zithromax [Azithromycin] for Atherosclerosis and its Related Disorders) trial
31. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study
32. Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes: The final report of the ROXIS Study
33. Chemokines and cell migration in secondary lymphoid organs
34. Atherosclerotic plaque rupture - Pathologic basis of plaque stability and instability
35. Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis
36. Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases
37. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro: Implications for atherosclerotic plaque stability
38. Differential expression of tissue factor protein in directional atherectomy specimen from patients with stable and unstable coronary syndromes
39. Macrophages, smooth muscle cells, and tissue factor in unstable angina: Implications for cell-mediated thrombogenicity in acute coronary syndromes
40. Fibrous cap formation or destruction - The critical importance of vascular smooth muscle cell proliferation, migration and matrix formation
41. Mechanisms of plaque rupture: Mechanical and biologic interactions
42. Atheroma morphology and mechanical strength: Look are important, after all - Lose the fat
43. Perturbation of the T-cell repertoire in patients with unstable angina
44. Cytokines and T cells in host defense
45. CD28/CTLA-4 and CD80/CD86 families: Signaling and function
46. - T cells in the aging immune system
47. Aging-related deficiency of CD28 expression in CD4+ T cells is associated with the loss of gene-specific nuclear factor binding activity
48. - T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity
49. Functional disruption of the CD28 gene transcriptional initiator in senescent T cells
50. Modulation of CD28 expression: Distinct regulatory pathways during activation and replicative senescence
51. T cell homeostasis in patients with rheumatoid arthritis
52. Thymic function and peripheral T-cell homeostasis in rheumatoid arthritis
53. - T cells
54. Functional subsets of CD4 T cells in rheumatoid synovitis
55. null T cells clonally expanded in rheumatoid arthritis
56. - T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems
57. The role of NK cells in innate immunity
58. Natural cytotoxicity receptors that trigger human NK-cell-mediated cytolysis
59. Regulation of T cell function by NK cell receptors for classical MHC class I molecules
60. - T cells from rheumatoid arthritis patients
61. null T cells are associated with defects in apoptotic pathways
62. A tale of two diseases: Atherosclerosis and rheumatoid arthritis
63. Expansion of unusual CD4+ T cells in severe rheumatoid arthritis
64. - T cells in rheumatoid arthritis
65. Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis: A retrospective cohort study from disease onset
66. Extra-articular rheumatoid arthritis: Prevalence and mortality
67. Mortality in rheumatoid arthritis: Have we made an impact in 4 decades?
68. Multiple mechanisms support oligoclonal T cell expansion in rheumatoid synovitis
69. Oligoclonal T cell proliferation in patients with rheumatoid arthritis and their unaffected siblings
70. Acute T-cell activation is detectable in unstable angina
71. Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina: Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes
72. Molecular fingerprint of interferon-gamma signaling in unstable angina
73. The role of STATs in transcriptional control and their impact on cellular function